The Experts below are selected from a list of 117 Experts worldwide ranked by ideXlab platform

Fabian A Abraham - One of the best experts on this subject based on the ideXlab platform.

  • yellow Mercuric Oxide a treatment of choice for phthiriasis palpebrarum
    British Journal of Ophthalmology, 1991
    Co-Authors: Isaac Ashkenazi, Howard Desatnik, Fabian A Abraham
    Abstract:

    Thirty-five patients presenting with phthiriasis palpebrarum were all treated with a regimen of 1% yellow Oxide of mercury ointment four times daily for 14 days. At the conclusion of treatment there was complete resolution of the signs and symptoms of the disease. No side effects due to the treatment were reported or detected. We have shown that 1% Mercuric Oxide ointment is both a safe and effective treatment for phthiriasis palpebrarum. We recommend it as the treatment of choice.

B P Codd - One of the best experts on this subject based on the ideXlab platform.

  • effect of mercury silver alloy composition on the open circuit voltage of cadmium Mercuric Oxide cells
    Journal of The Electrochemical Society, 1994
    Co-Authors: M L Kronenberg, B J Stein, B P Codd
    Abstract:

    To minimize the migration of mercury droplets when discharging cadmium/Mercuric Oxide (Cd/HgO) cells, silver powder is often blended with HgO powder in the cathode to promote formation of a solid Hg-Ag alloy. Even though only high purity materials are used, open-circuit cell voltages are much higher than what is normally observed when Ag powder is not present. There is also a significant variation in the open-circuit voltage (OCV) of a given lot of Cd/HgO cells. The authors hypothesized that this high OCV and cell voltage variation is at least partially attributed to uncontrolled very small quantities of mercury present in the HgO. The potential variations arise from the reduced activity of mercury in the Hg-Ag alloy. The experiments that were carried out and reported here support this hypothesis.

Isaac Ashkenazi - One of the best experts on this subject based on the ideXlab platform.

  • Yellow Mercuric Oxide: atreatmentofchoice for phthiriasis palpebrarum
    2020
    Co-Authors: Isaac Ashkenazi, Fabian Aabraham
    Abstract:

    Thirty-five patients presenting withphthiriasis palpebrarum wereall treated with aregimen of 1%yellow Oxideofmercury ointment four times daily for14days. Attheconclusion of treatment there wascomplete resolution ofthe signs andsymptoms ofthedisease. Noside effects duetothetreatment werereported or detected. We haveshownthat1%Mercuric Oxide ointment isbothasafeandeffective treatment forphthiriasis palpebrarum. We recommend itasthetreatment ofchoice. Phthiriasis palpebrarum, an odddermatoophthalmological condition often encountered in children, isaninfestation oftheeyelashes by Phthirus pubis (crab lice) andits ova. Thevarious suggested formsoftreatment' 12either have prohibitive side effects orpresent atechnically difficult anduncomfortable formoftreatment. Wetherefore reinstated theuseof1%Mercuric Oxide ointment.'3

  • yellow Mercuric Oxide a treatment of choice for phthiriasis palpebrarum
    British Journal of Ophthalmology, 1991
    Co-Authors: Isaac Ashkenazi, Howard Desatnik, Fabian A Abraham
    Abstract:

    Thirty-five patients presenting with phthiriasis palpebrarum were all treated with a regimen of 1% yellow Oxide of mercury ointment four times daily for 14 days. At the conclusion of treatment there was complete resolution of the signs and symptoms of the disease. No side effects due to the treatment were reported or detected. We have shown that 1% Mercuric Oxide ointment is both a safe and effective treatment for phthiriasis palpebrarum. We recommend it as the treatment of choice.

A Hartz - One of the best experts on this subject based on the ideXlab platform.

  • efficacy and safety of Mercuric Oxide in the treatment of bacterial blepharitis
    Antimicrobial Agents and Chemotherapy, 1990
    Co-Authors: R A Hyndiuk, E M Burd, A Hartz
    Abstract:

    A double-masked, placebo-controlled, randomized study was done to assess the safety and clinical and quantitative microbiologic efficacy of 1% Mercuric Oxide (yellow) ophthalmic ointment in the treatment of eyelid infections, i.e., bacterial blepharitis. A total of 39 patients with bacterial counts and clinical signs indicative of eyelid infection were treated twice daily for 7 days. Clinical biomicroscopic examination and quantitative microbiologic cultures were done just prior to initiation of treatment and again on days 3 and 7. Statistical analysis revealed a significant improvement in the clinical signs, bacterial count, cure rate, and improvement rate for subjects taking the active medication, compared with those taking the placebo on days 3 and 7. In addition, the medication was well tolerated.

Rajive Gupta - One of the best experts on this subject based on the ideXlab platform.